# A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses

> **Open Intelligence Dossier** · First detected: 2026-07-17 03:07 UTC · Category: Health

## Executive Summary
A Johns Hopkins-developed KRAS vaccine has demonstrated safety and durable immune responses in a trial focused on preventing pancreatic cancer in high-risk individuals.

## Intelligence Brief
Researchers have developed an experimental KRAS-targeting vaccine designed to prevent pancreatic ductal adenocarcinoma (PDAC) in people categorized as high-risk. According to reports from Johns Hopkins Medicine and the American Association for Cancer Research (AACR), the vaccine is intended to trigger an immune response before tumors even develop. The trial results indicate that the vaccine was safe for participants and succeeded in eliciting durable immune responses. This approach marks a shift in the fight against pancreatic cancer by moving the focus from treatment to early prevention through the interception of the disease in susceptible populations. Multiple medical and science outlets are emphasizing the feasibility and promise of this preventive strategy.


BioPharm International and Medical Xpress highlight the durability of the immune response generated by the Johns Hopkins-developed vaccine. Oncodaily features insights from Sandra Misale and Anirban Maitra regarding the interception of PDAC and the feasibility of KRAS-targeted vaccines in high-risk groups. Additional coverage from Inside Precision Medicine and Bioengineer.org stresses that the vaccine triggers these essential immune responses prior to the onset of tumor development, while Everyday Health describes the early trial as showing significant promise. To understand why this development is critical, it is necessary to look at the role of KRAS, which the vaccine specifically targets. Coverage from the AACR describes how vaccines are reshaping the fight against pancreatic cancer by transitioning the medical approach from treatment to prevention.


By focusing on high-risk individuals, the medical community aims to intercept the progression of the disease before it becomes advanced. This is a pivot toward precision medicine, as detailed by Inside Precision Medicine, focusing on specific genetic or risk-based targets like KRAS to prevent the emergence of pancreatic tumors in those most vulnerable. Moving forward, the focus will remain on the long-term efficacy of these durable immune responses in preventing the actual development of cancer. As reported by WDBJ7 and El Mundo America, the primary objective is to determine if this vaccine can reliably prevent pancreatic cancer in high-risk patients over time. Stakeholders and medical researchers will likely monitor whether these early safety and feasibility results can be scaled or transitioned into broader clinical applications to validate the preventive capabilities of the KRAS-targeted approach as a standard of care for high-risk populations.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| BioPharm International | Johns Hopkins-Developed KRAS Vaccine Shows Durable Immune Response in Pancreatic Cancer Prevention Trial | [Source Link](https://news.google.com/rss/articles/CBMi4AFBVV95cUxOc0tSMXRTdHNES1ktSktvX2tjcG55ZUtlbXpqZmY2R0FnZHFQU05wSnQ2TnFKLUJ4TTI5SHZuVlpFbkRXQ3BuMGd1bWoydFBwYlljYlRITUcwSzdhLTJrOGU3WHZKeFlnZW9XY2V4aEp6RUpta2ZGUVNZWVA0eFMzRGdNTlM2cVJZb3JQbVBvOTBDemVCTnRKV3h2YUQ2VXFkdTZoc2xJZmIxNFVrRDQybkY3NFFVcHRyVXhDRXZBT1ZtT251dWRxT2tjOVVMS0dQVXV3VFpRcW5vN3JzWFlKXw?oc=5) |
| Oncodaily | Sandra Misale: Intercepting PDAC in High-risk Individuals by KRAS-Targeting Vaccine | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTE5FVUVIY3pyZDZIMF9BZ05UbjRhLWZfVHNDWnBycS1VRVkzZ0dqeS14RUUzYjFmV3JQdEI1UWQyWE1pTWdQY29xZjBaQ1hwb0w3MklHY29UeU40TWR1UVNj?oc=5) |
| Inside Precision Medicine | Pancreatic Cancer Vaccine Triggers Immune Response Before Tumors Develop | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxQZk1OZ0RWNGIzdDNudC1mVHJoaXJNa3hTdzJpMzVEYWs0ZnZXVE9CUFRlUVZlZTItenlhdjlCN29kTG5aQVVRSzI5eXVHdndYaUM2dkdxZlgxWDgxUlZrbGp6NFI1cmNQTE84SlB4Smx5YXdrWE9DUkk3aGNtZ3BxY3N1V3JFd2Vqa0J3cU5lVk14UTZsakxtTnF0emxZOEhqZ3ppX1cxQlI4enMtZ3pnZ205QUlDMjE3Tl9WS0I3RkZqRnFxeW9MRg?oc=5) |
| WDBJ7 | HOMETOWN HEALTH: New vaccine could prevent pancreatic cancer in high risk patients | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxNS1pEVUlvU0twbHNXb1dJTlZXNmt2QUZlTXliSGM4MkJ3MEg5M1lKUjVsaUZVMjFaTXZOS0FYdGdHNV83T0JaTkQ2NlQ2ODJkTmxWSW9zN3BzV2R4VFVFdzk3MWhrSU5iMVJaOHNSd01yUmpFV0xvWERJdlhEUXU0a3ZmdWtkTU5NbUZPaWtRUXRNNThTUk1Xbml1ek1faHg5VHNWN0g2eXplVllTd2NjZlZ30gHGAUFVX3lxTE1JdksxYzcwSENwWnpDdGlyZE5ON0pVMnRyMzNPOGRHSnJBWUhYazYwSWtPVG9TQW1ZMVBUZzI4YjMyV3ZkeGs4d2ozREpFREpjeFFjUXh1UENURmlFWUIwZEkzVVNYYTZtdEJ6bjdFRV94THVZbXUxZzNRbG96Ry1QczdEWUxzYi1ZQVphemY2RU5lRXA1RGt4WFpRdzlMLUQ) |
| El Mundo America | Developing a Vaccine to Prevent Pancreatic Cancer in High-Risk Individuals | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxPUTRBYXFGX2tRRFdhb0VUREc3WUtXalN0cE02SWpaU2pUbDREOUlMbUFKWmVLcFp1N1piRDZTb0dwNFo5TWgzcE1Jdkt4SE90WjRES0FqRlVnQlZQaWxVNlp3cFBtMHgtWVA3UzVpQzlQMnhqei1MV2xMc1UxS1FhOU91UThDY3M5Z0ow?oc=5) |
| Everyday Health | Pancreatic Cancer Vaccine Shows Promise in Early Trial | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxNOUdnVWNDbGZQRTBXdjlrcHVGelR5ZnV1OGdvUnBMOGhMMmphUmw0M25MZnB1cmN6dHRPOWFtVVJuTzFoYWdva3Z1TnNsVzRnLTZucDVuSG5ydG5zYkMybTRpdlVUX1FMYVVVSG04QzF2akNwd3E0bWhURHVkMGh6VVlYam5qNzlkSkZRdUttcjRaTWphbVBlT1BUakpFS3V6eDE3bw?oc=5) |
| Bioengineer.org | Safe vaccine triggers durable immune responses to prevent pancreatic cancer in high-risk people | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxPakRuRXBrdlA2bi1FZXQ4WTFPRTFjam5pakR0T281OGViLUFiYVlUNXdhdHlLZDBtVVRaUlNnV1JoNEdjZlY3ZnI1T0F2R2l2RDlVTHMxcDBqeTdNa2ZZSWhDYmNIeDFHSjh6eUczNTZOMmVXNHJ3WFphLXVDNUpHZzhza2g0RmxKdDZSakJDN2xPcVRCSlJkVW5DM08zTXNLcEN6UEZKRFk4ZUFfcGk5RXFNUHNYYjBSSVlfVg?oc=5) |
| Medical Xpress | Experimental pancreatic cancer vaccine elicits durable immune responses in high-risk participants | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPUVFkcElYYS1WY2R0YzZ5cHBnRWh3YkEwNmtXallENTM5bjdTYmJPcGx5OHY4Q3NNOGk2SXBVYkZXOXFfVUxMR2g0SzRhV2Q2bF9kczBGVkJPYnN0WFc4QnA0NW9oWU9xeG1SWkdrcTV4RUhHVnV1cmd1RGJ0Xy16TTdURkx3SVptbGR5UTVyT21nakRT?oc=5) |
| Johns Hopkins Medicine | Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk | [Source Link](https://news.google.com/rss/articles/CBMi_AFBVV95cUxPMmkwMTQyQlQyOXcydThJR2p1ZmhlUEdMX2FkbjNkb0k5OU5XVF94bmRmTVZtcG1oc0RGN0o0RmxXUzVhSFA1NWJlQjhlUW1reXlaSWo4QmNCeTdxZzJjU1RXR0xnVmRLRzlDcWhqa3ZiOHo0WnlxVU9aTU5fN3VGSnR4ZUpjSVRObzEzcmJTejJZVWtTSnlFX2dVdWgzcVZ6bUltcUJKV015WVRyTlI2Ri1Ba256dzNyVjN4SXEtY0JjSjNLel85emphUzhrTWNMRk5Nb1pyaklpeWY1Rm5uWTdkU2s2UE10cFNwVHA3bTc1S3NTSFpJeVA3ZnE?oc=5) |
| Oncodaily | Anirban Maitra։ KRAS-Targeted Vaccine Feasibility in High-Risk Individuals for Pancreatic Cancer | [Source Link](https://news.google.com/rss/articles/CBMiYEFVX3lxTFA5dWh6M1BidkItcC1wcGFKQTRCY1lpODFraGNDUzBUWF9KVmtLeTIwcGs5QVU2YlNkSzItOU9xbHA5amExUXZaa1VqY05QQW1JZUxVdWEzRWRUU0ZmbHk2Qw?oc=5) |
| American Association for Cancer Research (AACR) | From Treatment to Prevention: How Vaccines Are Reshaping the Fight Against Pancreatic Cancer | [Source Link](https://news.google.com/rss/articles/CBMiyAFBVV95cUxNNFphSHZiSm9RS1RwZFhpZlRJZk5DQ010d1hGMVJ3NTV6RFRWNkhYREV3UjBFbjE2VFppNHR2MHZwXzRjUjF3VzM4eUhmVHNHZ3Q3Tk9sM0FBVjc4Y2dVWWE2MHJxWUtoUzFzZG5aVF9ySlhfaDhKT3BzMGZ1SkxrUVNaeE9ObUFQSUx6XzVVWmJBVzVhX1lqOVByNzcxcGFyUXo0TVIyLWZqdUxtME42UVg0OXNXazFod3dKaTlqSGRiTVBHWEU0OA?oc=5) |
| American Association for Cancer Research (AACR) | A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses | [Source Link](https://news.google.com/rss/articles/CBMi_wFBVV95cUxPZThtdHd4RGZzMHh3Xzk5eF8tcC1sYjRxeUhvc091c3EtQ21vc3l6bUw4T2w2MnRHQS05dEQ1c1BzQlJUWUtEeHhpWFljRURtZng4WUo5Q29rQmtfSlJ1ODNKOExjRUlqVEphVTQxV3FwRWFSN2NGQ1VfUVdEV2cxN1pJN0FXUWpnNU5HVFJWc19uTVZLQjBBTmFRam94S3liMEJ1dmNDcWpkQmloYm5Rel81eVFJVDJuellodUk3Z20yOEVsaEhaZ0E1NjhUTlc2UzNoLVJxYzFhUXk1Z3lVYXNhM1hoYWtYVEdfZlh3Rko2bGxjTFBxU042TkgtaTA?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-17/a-vaccine-to-prevent-pancreatic-cancer-in-high-risk-individuals-was-safe-and*